DexCom Investing Cash Flow decreased by 197.4% to -$298.50M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 397.9%, from $100.20M to -$298.50M.
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
net_cash_from_investing| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $363.20M | $29.00M | -$496.10M | -$411.80M | -$144.90M | -$194.10M | -$186.70M | -$555.90M | -$179.50M | $74.80M | -$188.90M | $210.30M | -$303.70M | $100.20M | $192.80M | $306.60M | -$298.50M |
| QoQ Change | — | -92.0% | <-999% | +17.0% | +64.8% | -34.0% | +3.8% | -197.8% | +67.7% | +141.7% | -352.5% | +211.3% | -244.4% | +133.0% | +92.4% | +59.0% | -197.4% |
| YoY Change | — | — | — | — | -139.9% | +60.9% | +54.7% | -283.6% | — | +140.1% | +66.0% | +217.2% | — | +34.0% | -8.3% | +201.0% | -397.9% |